Imaging in 2020
September 26-30, 1999

Organizers: Thomas Meade, Daniel Sullivan, and James Tatum


The Future of Medical Imaging
Dan Sullivan, National Cancer Institute

The Challenges and Promise of In Vivo Imaging at Cellular and Subcellular Resolutions
Scott Fraser, California Institute of Technology


Cancer Imaging: Meeting the Challenges
Janet Husband, Royal Marsden Hospital

Biological Imaging: From Metabolism to Gene Expression
Michael Phelps, UCLA

Advanced 3-D Microscopes and Multiscale Views of Nervous System
Mark Ellisman, UC San Diego

Diagnostic and Therapeutic Applications of Microbubbles
Evan Unger, University of Arizona

The Use of Dendrimers in Biomedical Targeting and Imaging Applications
Donald Tomalia, Michigan Molecular Institute

Imaging Signal Transduction with Genetically Encoded Indicators
Roger Tsien, UC San Diego

When Imaging is Not Enough? Neurochemistry in Real Time.
Brian Ross, Huntington Medical Research Institutes

Chair: Bill Strauss, Stanford University

Molecular and Cellular Imaging of the Cardiovascular System
Sam Wickline, Washington University

Assessing the Efficacy of Anti-Tumor Therapy using Radiolabeled Annexin V: Is there Life after Death?
Francis Blankenberg, Lucile Salter Packard Children’s Hospital

Brain Function and Neurochemistry by Magnetic Resonance?
Kamil Ugurbil, University of Minnesota

New Reagents for the Targeted Delivery of Metal Ions
Claude Meares, UC Davis

Keynote Address

Mapping the Human Brain in 2020 – What Did We Learn 21 Years Ago?
John Mazziota, UCLA

Chair: Tom Budinger, Lawrence Berkeley National Lab

Ultrasound in 2020
Kathy Ferrara, UC Davis

Imaging the Tumor Biology of Progression and Response in Prostate Cancer
Steven Larson, Memorial Sloan-Kettering Cancer Center

Three-Dimensional Magnetic Resonance Microscopy
G. Allen Johnson, Duke University

High-Resolution Optical Bioimaging: 20/20 by 2020?
Daniel Farkas, University of Pittsburgh

Can MRI Agents Compete in the Biochemical Imaging Arena?
Mike Tweedle, Bracco Research

Imaging Gene Delivery Expression In Vivo
Ralph Weissleder, Massachusetts General Hospital

Molecular Imaging: Advantages and Limitations
Ron Blasberg, Memorial Sloan-Kettering Cancer Center

Chair: Tom Meade,California Institute of Technology

Applications of PET in Assessment of Tumor Therapy
Michael Welch, Washington University

Smart MRI Contrast Without the Smart Chemistry
Alan Koretsky, Carnegie Mellon Research Institute

What Can We Learn from Noninvasive Measurements of the Tumoral Pharmacokinetics of Drugs? Scientific and Clinical Utility
Walter Wolf, University of Southern California

Seeing is Believing: Monitoring In Vivo Gene Expression by Magnetic Resonance Imaging
Tom Meade, California Institute of Technology

Comments are closed.